ADC Therapeutics S.A.
ADC Therapeutics S.A. (ADCT) Stock Forecast & Analyst Price Target
Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.
adct · stock forecast · 12 analysts (3M) · FMP · updated Jun 8, 2026
Analyst Rating & Consensus
Based on 12 Wall Street analysts in the past 3 months
Buy
12 analysts
consensus
Rating Breakdown
12-Month Price Target
High
$5.00
Consensus
$3.50
+239.8% upside
Low
$2.00
Median: $3.5 · Last Close: $1.03
12-Month Price Target Forecast
Historical closing prices + analyst 12-month price target forecast cone
Consensus Target
$3.50
239.8% upside
High Target
$5
385.4%
Low Target
$2
94.2%
Current Price
$1.03
as of today
Based on analyst price targets, the ADCT stock price prediction for the next 12 months ranges from $2 to $5. The consensus ADCT price forecast of $3.50 implies 239.8% upside from the current price of $1.03.
Short-Term Price Prediction
Algorithmically generated · Updated daily
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $1.03 | ↑ 0.00% |
1-day model range: $0.99–$1.07. Peak: $1.07 (+0.00%).
Long-Term Stock Price Prediction
Stock Forecast Based on Technical Analysis
14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency
Market Sentiment
NEUTRAL
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · ADCT · Jun 8, 2026
Latest Analyst Ratings & Upgrades
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-06-04 | RBC Capital | Downgrade ↓ | Outperform→Sector Perform |
| 2026-05-05 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2026-05-05 | RBC Capital | Maintains | Outperform→Outperform |
| 2026-03-23 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-10-16 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-08-13 | Guggenheim | Maintains | Buy→Buy |
| 2025-06-20 | RBC Capital | Maintains | Outperform→Outperform |
| 2025-06-13 | Guggenheim | Maintains | Buy→Buy |
| 2025-05-15 | RBC Capital | Maintains | Outperform→Outperform |
| 2025-03-31 | HC Wainwright & Co. | Maintains | Buy→Buy |
Wall Street analysts have recently issued updated ratings on ADC Therapeutics S.A. (ADCT) stock. Of the recent 70 rating actions, 1 were upgrades and 5 were downgrades. 12 analysts currently cover ADCT.
Analyst Recommendation Trends
ADCT analyst recommendation trends show decreasing buy-side sentiment over the past 6 months. Buy rating actions changed from 2 to 0 per month.
Financial Forecast: EPS & Revenue Estimates
Revenue This Year
$81M
↓ 65.0% YoY
Revenue Next Year
$125M
↑ 53.5% YoY
EPS This Year
$-0.84
EPS Next Year
$-0.65
↓ 23.0% YoY
EPS ForecastReported vs Estimated
Analysts forecast ADCT EPS of $-0.84 for the current fiscal year, based on estimates from 4 analysts. The ADCT revenue forecast is $81M for the current year. These are analyst consensus estimates via FMP / S&P Global.
About Forecast & Price Prediction
The ADCT stock forecast is supported by two independent data sources: analyst consensus ratings from 12 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus ADCT price target is $3.50 (+239.8% upside), with an analyst consensus of Buy.
The ADCT short-term stock prediction for tomorrow is $1.03 (+0.00%).
ADC Therapeutics S.A. trades on NYSE under the ticker ADCT. The ADCT stock outlook for 2027 is broadly positive, supported by a Buy consensus among 50% of covering analysts.
Frequently asked questions
ADCT forecast · 8 questionsAccording to 12 Wall Street analysts, the average 12-month ADCT price target is $3.50, with a high forecast of $5.00 and a low of $2.00. The median price target is shown in the chart above when available. This implies +239.8% potential upside from the current price of $1.03.
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.